首页> 外文期刊>World Journal of Gastroenterology >Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells
【24h】

Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells

机译:丹参酮II-A对人肝癌细胞的生长抑制和凋亡诱导

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To evaluate the effects of tanshinone II-A on inducing growth inhibition and apoptosis of human hepatocellular carcinoma (HCC) cells. METHODS: The human hepatocellular carcinoma cell line SMMC-7721 was used for the study. The cells were treated with tanshinone II-A at different doses and different times. Cell growth and proliferation were measured by MTT assay, cell count and colony-forming assay. Apoptosis induction was detected by microscopy, DNA ladder electrophoresis and flow cytometry. RESULTS: In MTT assay, the inhibitory effect became gradually stronger with the passage of time, 24, 48, 72 and 96 h after treatment with tanshinone II-A, and the most significant effect was observed at 72 h. On the other hand, the increase of doses (0.125, 0.25, 0.5, 1.0 mg/L tanshinone II-A) resulted in enhanced inhibitory effect. The growth and proliferation of SMMC-7721 cells were obviously suppressed in a dose- and time-dependent manner. The results of cell count were similar to that of MTT assay. In colony-forming assay, the colony-forming rates were obviously inhibited by tanshinone II-A. In tanshinone II-A group, the morphology of cellular growth inhibition and characteristics of apoptosis such as chromatin condensation, crescent formation, margination and apoptotic body were observed under light and transmission electron microscopes. DNA ladder of cells was presented in electrophoresis. The apoptosis index (AI) was 16.9% (the control group was 4.6%) in flow cytometry. The cells were arrested in G_0/G_1 phase, and the expressions of apoptosis-related genes bcl-2 and c-myc were down-regulated and fas, bax, p53 up-regulated. CONCLUSION: Tanshinone II-A could inhibit the growth and proliferation of HCC cell effectively in vitro by apoptosis induction, which was associated with up-regulation of fas, p53, bax, expression and down-regulation of bcl-2 and c-myc.
机译:目的:评价丹参酮II-A对人肝癌(HCC)细胞生长抑制和凋亡的影响。方法:以人肝癌细胞SMMC-7721为研究对象。用丹参酮II-A以不同剂量和不同时间处理细胞。通过MTT测定,细胞计数和集落形成测定来测量细胞的生长和增殖。通过显微镜检查,DNA梯形电泳和流​​式细胞术检测凋亡诱导。结果:MTT法检测丹参酮II-A后24、48、72、96 h随时间的推移,抑制作用逐渐增强,最显着的是72 h。另一方面,增加剂量(0.125、0.25、0.5、1.0 mg / L丹参酮II-A)导致抑制作用增强。 SMMC-7721细胞的生长和增殖明显受到剂量和时间依赖性的抑制。细胞计数的结果与MTT测定相似。在菌落形成试验中,丹参酮II-A明显抑制了菌落形成速率。在丹参酮II-A组中,在光镜和透射电镜下观察到细胞生长抑制的形态学和染色质浓缩,新月形成,边缘化和凋亡小体的凋亡特征。电泳显示细胞的DNA阶梯。流式细胞仪检测细胞凋亡指数(AI)为16.9%(对照组为4.6%)。细胞被阻滞在G_0 / G_1期,凋亡相关基因bcl-2和c-myc的表达下调,而fas,bax,p53的表达上调。结论:丹参酮II-A可通过诱导细胞凋亡有效抑制HCC细胞的生长和增殖,这与fas,p53,bax的表达上调,bcl-2和c-myc的表达下调有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号